These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36758176)

  • 1. IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model.
    Lutz V; Hellmund VM; Picard FSR; Raifer H; Ruckenbrod T; Klein M; Bopp T; Savai R; Duewell P; Keber CU; Weigert A; Chung HR; Buchholz M; Menke A; Gress TM; Huber M; Bauer C
    Cancer Immunol Res; 2023 Apr; 11(4):421-434. PubMed ID: 36758176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL18 Receptor Signaling Inhibits Intratumoral CD8
    Nasiri E; Student M; Roth K; Siti Utami N; Huber M; Buchholz M; Gress TM; Bauer C
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL18 at the Crossroads between Chronic Inflammation and T-cell Exhaustion in Pancreatic Cancer.
    Stromnes IM
    Cancer Immunol Res; 2023 Apr; 11(4):400. PubMed ID: 36897261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter.
    Wang J; Sun C; Gerdes N; Liu C; Liao M; Liu J; Shi MA; He A; Zhou Y; Sukhova GK; Chen H; Cheng XW; Kuzuya M; Murohara T; Zhang J; Cheng X; Jiang M; Shull GE; Rogers S; Yang CL; Ke Q; Jelen S; Bindels R; Ellison DH; Jarolim P; Libby P; Shi GP
    Nat Med; 2015 Jul; 21(7):820-6. PubMed ID: 26099046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion.
    Teagle AR; Castro-Sanchez P; Brownlie RJ; Logan N; Kapoor SS; Wright D; Salmond RJ; Zamoyska R
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8
    Seo H; Chen J; González-Avalos E; Samaniego-Castruita D; Das A; Wang YH; López-Moyado IF; Georges RO; Zhang W; Onodera A; Wu CJ; Lu LF; Hogan PG; Bhandoola A; Rao A
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12410-12415. PubMed ID: 31152140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytes promote interleukin-18 binding to its receptors during abdominal aortic aneurysm formation in mice.
    Liu CL; Ren J; Wang Y; Zhang X; Sukhova GK; Liao M; Santos M; Luo S; Yang D; Xia M; Inouye K; Hotamisligil GS; Lu G; Upchurch GR; Libby P; Guo J; Zhang J; Shi GP
    Eur Heart J; 2020 Jul; 41(26):2456-2468. PubMed ID: 31821481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy.
    Zhou L; Velegraki M; Wang Y; Mandula JK; Chang Y; Liu W; Song NJ; Kwon H; Xiao T; Bolyard C; Hong F; Xin G; Ma Q; Rubinstein MP; Wen H; Li Z
    J Clin Invest; 2024 May; 134(14):. PubMed ID: 38787791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 regulates tumor-reactive CD8
    Liu Y; Zhou N; Zhou L; Wang J; Zhou Y; Zhang T; Fang Y; Deng J; Gao Y; Liang X; Lv J; Wang Z; Xie J; Xue Y; Zhang H; Ma J; Tang K; Fang Y; Cheng F; Zhang C; Dong B; Zhao Y; Yuan P; Gao Q; Zhang H; Xiao-Feng Qin F; Huang B
    Nat Immunol; 2021 Mar; 22(3):358-369. PubMed ID: 33432230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymocyte selection-associated high mobility box protein regulates T lymphocytes exhaustion in patients with myelodysplastic syndromes by inhibiting PI3K/AKT/mTOR pathway.
    Niu H; Zhang M; Liu M; Yang L; Yang L; Ren J; Yu Y; Liu Y; Xing L; Shao Z; Wang H
    Hematol Oncol; 2024 Jan; 42(1):e3224. PubMed ID: 37712442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens.
    Miller AM; Bahmanof M; Zehn D; Cohen EEW; Schoenberger SP
    Cancer Immunol Res; 2019 Jan; 7(1):40-49. PubMed ID: 30482746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8
    Tillé L; Cropp D; Charmoy M; Reichenbach P; Andreatta M; Wyss T; Bodley G; Crespo I; Nassiri S; Lourenco J; Leblond MM; Lopez-Rodriguez C; Speiser DE; Coukos G; Irving M; Carmona SJ; Held W; Verdeil G
    Nat Immunol; 2023 Oct; 24(10):1645-1653. PubMed ID: 37709986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic T cell exhaustion in a murine model of bacterial infection in the setting of pre-existing malignancy.
    Mittal R; Wagener M; Breed ER; Liang Z; Yoseph BP; Burd EM; Farris AB; Coopersmith CM; Ford ML
    PLoS One; 2014; 9(5):e93523. PubMed ID: 24796533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection.
    Xu A; Wang R; Freywald A; Stewart K; Tikoo S; Xu J; Zheng C; Xiang J
    Biochem Biophys Res Commun; 2017 Mar; 484(3):662-667. PubMed ID: 28153727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8
    Kundu ST; Rodriguez BL; Gibson LA; Warner AN; Perez MG; Bajaj R; Fradette JJ; Class CA; Solis LM; Rojas Alvarez FR; Wistuba II; Diao L; Chen F; Sachdeva M; Wang J; Kirsch DG; Creighton CJ; Gibbons DL
    Genes Dev; 2022 May; 36(9-10):582-600. PubMed ID: 35654454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activation.
    Teague RM; Tempero RM; Thomas S; Murali-Krishna K; Nelson BH
    J Immunol; 2004 Sep; 173(5):3131-9. PubMed ID: 15322173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
    Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
    Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.